同时公司授权给$BAUSCH HE...查看全文
北京时间29日晚,药品与医疗设备企业博士医疗公司(Bausch Health Companies,BHC.T)周五股价降至27年来最低水平,此前该公司证实其治疗肠易激综合征(Irritable Bowel Syndrome,IBS)的抗生素药物利福昔明(... 网页链接
8月7日BauschHealth(股票代码:BHC)公布财报,公告显示公司2018财年第二财季净利润为-8.73亿美元,同比下降2197.37%;营业收入为21.28亿美元,同比下跌4.7%。 BauschHealthCompani ... 网页链接
$Bausch Health(BHC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000885590-24-000019 Act: 34 Size: 12 MB 网页链接
$Bausch Health(BHC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000885590-24-000016 Act: 34 Size: 744 KB 网页链接
$Bausch Health(BHC)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-017937 Act: 34 Size: 12 MB 网页链接
$Bausch Health(BHC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-24-017941 Act: 34 Size: 1 MB 网页链接
$Bausch Health(BHC)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-017943 Act: 34 Size: 6 MB 网页链接
$Bausch Health(BHC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-011591 Size: 4 KB 网页链接
$Bausch Health(BHC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-011592 Size: 4 KB 网页链接
$Bausch Health(BHC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-011594 Size: 4 KB 网页链接
$Bausch Health(BHC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-011596 Size: 4 KB 网页链接
$Bausch Health(BHC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-008129 Size: 6 KB 网页链接